Genomics has revolutionized research into infectious diseases and is poised to revolutionize the clinic. Through the activities in this technology core, we will provide high-throughput genome sequencing and analysis focused on understanding host, pathogen, and microbiome interactions as determinants of disease outcome. We will provide state-of-the-art, large-scale, high-throughput sequencing data for analysis of genomes, transcriptomes, metagenomes, metatranscriptomes, and microRNAs using the best methodologies and technologies available. We will use a portion of our combined annual sequencing capacity, which is now >38 terabases of high-quality, passed-filter data per year, to sequence infectious disease agents, their hosts, and their vectors. Continued cost savings while maintaining high quality and quantity sequencing will be obtained through: (a) the extensive use of standard operating procedures (SOPs) and (b) evaluation, development, and incorporation of enhancements, modifications and improvements as they become available. This will include the addition of new sequencing platforms, more efficient protocols, and more robust methodologies. In order to better sequence host/microbe mixed specimens, we propose to test targeted enrichment systems on PacBio genomic libraries and on lllumina transcriptome libraries to measure expression. We will continue to improve our abilities to assemble genomes/transcriptomes, identify open reading frames, and annotate gene function, particularly with respect to metagenome and metatranscriptome data. We will provide bioinformatic pipelines to analyze data types that transect multiple projects including measuring genetic variation in populations and communities. Comparative genomics will be enabled through pipelines for ortholog predictions and pan genome analyses. Transcriptome analyses will include RNAseq data alignment and visualization, differential expression analysis, heterogeneous RNAseq analysis, novel transcript identification, and miRNAseq analysis. Analysis of microbiome data will include analysis of 16S rRNA amplicons, whole metagenome shotgun classification, and metatranscriptome analysis. Stable, robust pipelines with the potential to have long lasting value will be implemented in the Cloud Virtual Resource (CloVR) to be distributed to the research community as easy-to-use virtual machines. When multiple data types are available, they will be integrated and visualized using Sybil and Circleator.

Public Health Relevance

Infectious agents are leading causes of death worldwide with the potential to be preventable through vaccination. In the US, infectious respiratory diseases are a leading cause of death. This core will provide data and analysis to support the research of some of the nation's pre-eminent genomics researchers focused on developing new diagnostics, treatment, and vaccines for the fight against infectious disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI110820-01
Application #
8711763
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2014-04-15
Project End
2019-03-31
Budget Start
2014-04-15
Budget End
2015-03-31
Support Year
1
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Type
DUNS #
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Sistrunk, Jeticia R; Nickerson, Kourtney P; Chanin, Rachael B et al. (2016) Survival of the Fittest: How Bacterial Pathogens Utilize Bile To Enhance Infection. Clin Microbiol Rev 29:819-36
Chibucos, Marcus C; Soliman, Sameh; Gebremariam, Teclegiorgis et al. (2016) An integrated genomic and transcriptomic survey of mucormycosis-causing fungi. Nat Commun 7:12218
Conti, Heather R; Bruno, Vincent M; Childs, Erin E et al. (2016) IL-17 Receptor Signaling in Oral Epithelial Cells Is Critical for Protection against Oropharyngeal Candidiasis. Cell Host Microbe 20:606-617
Hazen, Tracy H; Leonard, Susan R; Lampel, Keith A et al. (2016) Investigating the Relatedness of Enteroinvasive Escherichia coli to Other E. coli and Shigella Isolates by Using Comparative Genomics. Infect Immun 84:2362-71
Kumar, Nikhil; Lin, Mingqun; Zhao, Xuechu et al. (2016) Efficient Enrichment of Bacterial mRNA from Host-Bacteria Total RNA Samples. Sci Rep 6:34850
Takala-Harrison, Shannon; Jacob, Christopher G; Arze, Cesar et al. (2015) Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis 211:670-9
Ouattara, Amed; Barry, Alyssa E; Dutta, Sheetij et al. (2015) Designing malaria vaccines to circumvent antigen variability. Vaccine 33:7506-12
Bruno, Vincent M; Shetty, Amol C; Yano, Junko et al. (2015) Transcriptomic analysis of vulvovaginal candidiasis identifies a role for the NLRP3 inflammasome. MBio 6:
Hazen, Tracy H; Kaper, James B; Nataro, James P et al. (2015) Comparative Genomics Provides Insight into the Diversity of the Attaching and Effacing Escherichia coli Virulence Plasmids. Infect Immun 83:4103-17
Sahl, Jason W; Sistrunk, Jeticia R; Fraser, Claire M et al. (2015) Examination of the Enterotoxigenic Escherichia coli Population Structure during Human Infection. MBio 6:e00501

Showing the most recent 10 out of 20 publications